nuscale

What is happening to SMR stock? NuScale Power trades near $5.60 after falling more than 60% from a 52-week high of $45.54. Three forces drove the drop.

First, revenue collapsed. Trailing twelve-month sales sit at roughly $10.69 million, down 81%, as the RoPower engineering work ended. Q2 2026 revenue was $0.1 million. Second, higher interest rates punished pre-revenue growth names across the nuclear sector. SMR stock carries a beta of 2.37, amplifying every move. Third, the ENTRA1 and TVA pipeline of up to 6 gigawatts remains under negotiation, and the market is tired of waiting.

The Doosan manufacturing contract signed in late October is a supply-chain milestone, not a revenue one. Q3 earnings on November 5 will test whether the $1.9 billion cash cushion and deployment progress are enough to stabilize the stock. Not a guaranteed outcome in either direction.

#SMR #NuScale #NuclearStock #StockMarket #SmallModularReactor

NuScale Power reports Q3 2026 earnings on November 5. SMR stock trades near $5.60 after losing more than 60% from its 52-week high of $45.54. Revenue is the wrong thing to focus on here. Q2 came in at roughly $0.1 million, and Q3 will not look much different.

What I watch instead: total liquidity, which stood at $1.9 billion as of Q2, giving the company roughly four to five years of runway. If that number holds above $1.7 billion, the thesis stays intact. The Doosan manufacturing contract signed in late October moves the program from material procurement into first-unit production. That is progress, but it is supply-chain progress, not a binding customer order.

The real catalyst is a definitive agreement with TVA through the ENTRA1 partnership, targeting up to 6 gigawatts. Until that converts from negotiation to contract, SMR stock stays in wait-and-see territory. Not a guaranteed outcome either way.

#SMR #NuScale #NuclearEnergy #EarningsCall #StockAnalysis

The SMR stock price dropped roughly 27% in three weeks during October, from above $7.60 to near $5.60. Three forces drove the sell-off.

Higher interest rates continued to punish pre-revenue growth stocks. NuScale carries a beta of 2.37, amplifying every broad market move. Analyst downgrades from UBS ($6 target, Sell), Barclays ($5, Underweight), and Citi ($4, Sell) accelerated selling. The ENTRA1 and TVA pipeline of up to 6 gigawatts remained non-binding, and the market stopped giving credit for potential.

The balance sheet provides a counterargument. Total liquidity near $1.9 billion gives NuScale four to five years of runway. The Doosan manufacturing contract moves the program into first-unit production. Q3 earnings on November 5 will test whether these are enough to stop the bleeding. Not a guarantee either way.

#SMR #NuScale #StockPrice #NuclearEnergy #Drawdown

$SMU.ETF just had a brutal 10%+ sell-off, dropping to around $6.25 before buyers stepped back in.
Now price is trying to recover around the $6.50–$6.60 area.


📊 Levels I’m watching: • $6.25 → key support
• $6.60 → first resistance
• $7.00–$7.20 → next upside zone
If buyers reclaim $6.60, the rebound could get interesting.
But losing $6.25 would completely change the setup.
Bounce or another breakdown? 👀
#SMU #SMR #NuScale #NuclearEnergy #stocks #Trading #etf